Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

Making proteins for research or therapies often starts ... ExpreS2ion Biotechnologies is now using similar technology to develop a vaccine for HER2-expressing cancers, currently starting a first ...

In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...

OS Therapies ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, CEO, and Gerald ...

Zanidatamab is an HER2-targeted bispecific antibody with multiple ... of action as dual HER2 signal blockade and removal of HER2 protein from the cell surface – this potent effector function ...

Scientists from UNIGE have developed synthetic molecules that mimic antibodies. They could revolutionize the treatment of ...

CircRNAs primarily function as sponges for microRNAs (miRNAs ... progesterone, and the HER2 protein 3. Similarly, circRNAs have also been shown to play roles in human diseases, including cancer ...